Memphasys & Monash IVF commence clinical trial of FELIX. Trial planning has commenced with enrolment of first patients expected to commence in the March quarter of 2022. The trial is expected to be completed within the December quarter of 2022.
We will have published papers about the in vivo performance of the Felix device in about 6 months. India would not have reordered without success in vivo so we do have great reassurances for a favorable outcome from the clinical trial.
I will leave it in the bottom drawer for now.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-100
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MEM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.06M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 5790554 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 2764766 | 4 |
View Market Depth
| Last trade - 13.35pm 05/07/2024 (20 minute delay) ? |
| MEM (ASX) Chart |
Day chart unavailable